"As you may know, Peritoneal Dialysis (PD) is the most common dialysis therapy for patients who choose to receive their dialysis treatment at their home," the National Renal Administrators Association (NRAA - which can trace its roots back to 1977) wrote to the Food and Drug Administration (FDA), asking them to allow Baxter Healthcare (producer of Peritoneal Sterile Solution in the US) to import Peritoneal Sterile Solution due to a severe shortage. Should this be a cause for relief and even celebration for the 26,114 Chronic Kidney Disease patients who conduct Peritoneal Dialysis, or should it be a matter of continued concern?
You may recall that KidneyBuzz.com announced this Peritoneal Sterile Solution shortage in a September 15th article, Critical Dialysis Solution Shortage Concerns Chronic Kidney Disease Especially Peritoneal Patients. While a shortage in saline has impacted both Hemodialysis and Peritoneal Dialysis patients alike, according to the NRAA this huge supply interruption for Peritoneal Dialysis solution specifically may result in Dialysis Care Facilities being unable to offer Peritoneal Dialysis as a treatment option due to, "limitations set by Baxter on accepting new PD patient orders."
As a Dialysis patient you can imagine that stopping Peritoneal Dialysis at some clinics would not only place a huge burden on the Hemodialysis Centers themselves, but scheduling interruptions and staff limitations would also impact existing Hemodialysis patients. Needless to say, Peritoneal Dialysis Patients would experience significant emotional, financial, and transportation hardships as a result of switching their existing treatment to In-Center Hemodialysis.
The news is now spreading that the FDA did in fact decide to allow Baxter to import Peritoneal Sterile Solution made in Ireland to help offset the current shortage in the United States. The National Kidney Foundation noted that, "While the solution manufactured in Ireland is the same solution made in the U.S., there are some differences in the packaging including the connectors and the quantity of solution in each bag."
Given the fact that the FDA has approved the use of this imported solution, Dialysis patients, both Peritoneal and Hemodialysis, should be relieved that a solution (no pun intended) has been identified to help solve the shortage. Peritoneal patients should (1) recognize that they may receive a different looking package, as stated above; and (2) remain watchful to ensure that they do not experience any unintended side effects, as the solution from Ireland is regulated by quality standards set by the European Union (EU) and not the FDA.
What do you think about the Peritoneal Sterile Solution shortage and the approach taken to correct it? Leave a comment on the KidneyBuzz.com Facebook Fan Page and join the robust conversation on this and other topics by clicking on the following link (https://www.facebook.com/pages/KidneyBuzz/347471888696381?ref=hl). Also, for more Daily Breaking News & Information regarding how Chronic Kidney Disease and Diabetic patients can better manage their lives, turn to your trusted resource, KidneyBuzz.com first every day.
Most Popular Stories:
"Baxter's Irish Dialysis Production Issue Not Resolved." The Wall Street Journal. Dow Jones & Company.
"NRAA Asks FDA to Consider Allowing Import of PD Solutions, Warns of Hardships If Shortage Continues." Http://www.nephrologynews.com/. Grand View Media Group.
"Letter to Peritoneal Dialysis (PD) Patients. National Kidney Foundation."